1191TiP Nivolumab-ipilimumab with cfDNA-guided treatment intensification as a chemotherapy-sparing strategy in metastatic non-small cell lung cancer (ATLAS)
| Autor: | Corke, L., García Pardo de Santayana, M., Meteleva, K., Shepherd, F.A., Bradbury, P., Eng, L., Kuang, S., Cabanero, M., Rogalla, P., Liu, G., Tsao, M-S., Pugh, T.J., Wang, B., Ohashi, P., Leighl, N., Sacher, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1093-S1093 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|